Olprinone

also known as Loprinone · Olprinona

Developed for: acute respiratory distress syndrome
Investigated by: Fudan University · Guangdong Provincial People's Hospital · Ningbo No. 1 Hospital · Peking Union Medical College Hospital · Renmin Hospital of Wuhan University · Second Affiliated Hospital, School of Medicine, Zhejiang University
+5 more
· Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University · The First Affiliated Hospital of Zhengzhou University · The Second Affiliated Hospital of Harbin Medical University · Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · West China Hospital

today NCT05658692 · Ph 4

2023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT05658692	Oct 2022 → Oct 2023	acute respiratory distress syndrome	Second Affiliated Hospital, School of Medicine, Zhejiang University	Unknown	No outcome recorded

Every value below carries the sentence it was read from. 2 sources stand behind the page.

Field	Value	Cited text
Known as	Olprinone	“Olprinone” NCT05658692 ↗
Known as	Loprinone	ChEMBL registry synonym — accepted as the source's own label CHEMBL1474900 ↗
Known as	Olprinona	ChEMBL registry synonym — accepted as the source's own label CHEMBL1474900 ↗
Modality	Small molecule	— CHEMBL1474900 ↗